Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Prospector who wrote (981)	6/17/1998 11:07:00 AM
From: Gwolf	Read Replies (2) \| Respond to of 5402

" The Law Of Risk vs Reward "...................... When an investor contemplates purchasing any security they must take into consideration their potential risk as well as the potential reward. SGNC has been basing at $.50 for the last 2 years, if the stock failed it would return to that level, so the downside risk is $.50. In 1995 the stock was in the $2-3 range with plenty of potential competition, no funding and no clinical trials on the horizon. If you go back to my post 766 you can derive your own upside potential for the stock. Obviously the stock is in a much better position now than it was in 1995. The competition has steadily failed in their attempts, the company is very close to receiving their funding to begin animal testing. If the stock was worth $2-3 then it should be worth at least that now. I personally think the "Anticipated Market Value" is higher than the $2-3 range, but each person has to make their own determination. I try to buy stocks that I think have at least a 3 to 1 risk reward ratio and SGNC safely fits into that category for me. Do your own Due Diligence, call Dr. Drees and then stop and ask yourself where this stock fits into your risk vs reward scenario. Good luck to everyone. Gwolf